Diagnosis and appropriate treatment of malaria Infections and Infestations Unspecified malaria
Conditions
Interventions
The study will involve 1500 participants who will be followed-up 4 days after initial enrollment and testing to assess self-reported adherence (the recommended malaria treatment regimen is 3 days). Th
Sponsors
University of California, San Francisco (USA)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Adult aged over 17 years and having purchased malaria drugs for either him/herself or an accompanying minor at an enrolled study site 2. Customers must be willing to be assigned to any of the study intervention groups 3. Participating drugs shops must sell at least one type of antimalarial drug
Exclusion criteria
Exclusion criteria: 1. Pregnant women who are seeking malaria treatment for herself are excluded because the recommended treatment for malaria is a different drug regimen than one than the study can provide 2. Any individual seeking treatment for illnesses other than malaria 3. Any adult who is purchasing malaria for a minor and the minor is not present at the time of enrollment 4. Because the study involves a follow-up survey conducted via phone, participants who cannot provide at least one phone number at which they can be reached are excluded 5. Drug shops that do not sell antimalarial drugs are excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Malaria rapid diagnostic test result measured at baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessed 4 days after enrollment and testing and will include: 1. Self-reported treatment with anti-malarial medication 2. Self-reported treatment with non-antimalarial medications 3. Perceptions of drug shop vendors ability to perform rapid diagnostic tests 4. Perceptions of rapid diagnostic tests in general 5. Cost effectiveness 6. Perceptions of the text message reminders | — |
Countries
Nigeria
Outcome results
None listed